Skip to main content
A

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2026-04-26 Interim / Quarterly Rep…
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
AN1 - Appendix 4C & Activity Report for Q3 FY2026 7 pages 578.7KB
Interim / Quarterly Report Classification · 1% confidence The document is an 'Appendix 4C' quarterly cash flow report for Anagenics Limited, which is a standard regulatory filing required by the Australian Securities Exchange (ASX) for entities subject to Listing Rule 4.7B. It contains detailed financial data regarding cash flows, operating activities, and financing facilities for the quarter ended 31 March 2026. While it includes a brief activity report, the core of the document is the standardized financial statement required for quarterly reporting. Therefore, it is classified as an Interim/Quarterly Report (IR). Q3 2026
2026-04-26 English
Notification of cessation of securities - AN1 4 pages 14.7KB
Share Issue/Capital Change Classification · 1% confidence The document is an ASX Appendix 3H form notifying the cessation (expiry) of unquoted equity options (3,500,000 securities) and detailing changes to issued capital. It is a formal announcement of a capital change rather than an earnings release, call transcript, or AGM material. This fits the "Share Issue/Capital Change" category (SHA).
2026-04-16 English
AN1 - Director Appointment 1 page 234.4KB
Regulatory Filings
2026-03-01 English
Appendix 3X MR JOSHUA GORDON 2 pages 163.6KB
Regulatory Filings
2026-03-01 English
Change of Director's Interest Notice 2 pages 274.2KB
Regulatory Filings
2026-02-26 English
Appendix 4D 1H FY26 DEC 2025 1 page 180.0KB
Regulatory Filings
2026-02-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.